• 1
    Dzau VJ, Antman EM, Black HR, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: Part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006;114:28502870.
  • 2
    Ruilope LM, Van Veldhuisen DJ, Ritz E, et al. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol. 2001;38:17821787.
  • 3
    Taal MW, Brenner BM. Renal risk scores: progress and prospects. Kidney Int. 2008;73:12161219.
  • 4
    Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease. Effects on Cardiovascular system. Circulation. 2007;116:8597.
  • 5
    Facila L, Bertomeu V, Bertomeu-González V, et al. Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens. 2009;11:302307.
  • 6
    Bezante GP, Viazzi F, Leoncini G, et al. Coronary flow reserve is impaired in hypertensive patients with subclinical damage. Am J Hypertens. 2009;22:191196.
  • 7
    Nardi E, Palermo A, Mulé G, et al. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens. 2009;27:633641.
  • 8
    Amman K, Tyralla K. Cardiovascular changes in chronic renal failure—pathogenesis and therapy. Clin Nephrol. 2002;58(Suppl 1):S62S72.
  • 9
    Sciaretto S, Pontremoli R, Agabiti Rosei E, et al. Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-developing education and awareness on microalbuminuria in patients with hypertensive disease study. J Hypertens. 2009;27:410417.
  • 10
    Havranek EP, Froshaug DB, Enserman CD, et al. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med. 2008;121:870875.
  • 11
    Ruilope LM, Salvetti A, Jamerson K, et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol. 2001;12:218225.
  • 12
    Tsioufis C, Vezali E, Tsiachris D, et al. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a greek 6-year-follow-up study. J Hypertens. 2009;27:744752.